Purification and characterization of a recombinant human testican-2 expressed in baculovirus-infected Sf9 insect cells

Protein Expression and Purification

Volumn 58, Issue 1, 2008, Pages 132-139

  Pavšič, Miha ^a   Vito, Turk ^a   Lenarčič, Brigita ^a,b  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

C1q complement component; Modular protein; Sf9 insect cells; Testican; Thyropin

Indexed keywords

CATHEPSIN; COMPLEMENT COMPONENT C1Q; PROTEOGLYCAN; RECOMBINANT PROTEIN; SPOCK2 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANIMAL; ARMYWORM; ARTICLE; BACULOVIRUS; CELL LINE; CHEMISTRY; CIRCULAR DICHROISM; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY;

ANIMALS; BACULOVIRIDAE; CATHEPSINS; CELL LINE; CIRCULAR DICHROISM; COMPLEMENT C1Q; HUMANS; PROTEOGLYCANS; RECOMBINANT PROTEINS; SPODOPTERA;

HEXAPODA; LEPIDOPTERA; SPODOPTERA FRUGIPERDA;

EID: 38349131587     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.09.010     Document Type: Article

References (42)

1. Alliel P.M., Perin J.P., Jolles P., and Bonnet F.J. Testican, a multidomain testicular proteoglycan resembling modulators of cell social behaviour. Eur. J. Biochem. 214 (1993) 347-350
2. Bonnet F., Perin J.P., Charbonnier F., Camuzat A., Roussel G., Nussbaum J.L., and Alliel P.M. Structure and cellular distribution of mouse brain testican. Association with the postsynaptic area of hippocampus pyramidal cells. J. Biol. Chem. 271 (1996) 4373-4380
3. Edgell C.J., BaSalamah M.A., and Marr H.S. Testican-1: a differentially expressed proteoglycan with protease inhibiting activities. Int. Rev. Cytol. 236 (2004) 101-122
4. Marr H.S., Basalamah M.A., Bouldin T.W., Duncan A.W., and Edgell C.J. Distribution of testican expression in human brain. Cell Tissue Res. 302 (2000) 139-144
5. Vannahme C., Schubel S., Herud M., Gosling S., Hulsmann H., Paulsson M., Hartmann U., and Maurer P. Molecular cloning of testican-2: defining a novel calcium-binding proteoglycan family expressed in brain. J. Neurochem. 73 (1999) 12-20
6. Marr H.S., and Edgell C.J. Testican-1 inhibits attachment of Neuro-2a cells. Matrix Biol. 22 (2003) 259-266
7. Schnepp A., Komp Lindgren P., Hulsmann H., Kroger S., Paulsson M., and Hartmann U. Mouse testican-2. Expression, glycosylation, and effects on neurite outgrowth. J. Biol. Chem. 280 (2005) 11274-11280
8. Bocock J.P., Edgell C.J., Marr H.S., and Erickson A.H. Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L. Eur. J. Biochem. 270 (2003) 4008-4015
9. Lenarčič B., and Bevec T. Thyropins-new structurally related proteinase inhibitors. Biol. Chem. 379 (1998) 105-111
10. Meh P., Pavšič M., Turk V., Baici A., and Lenarčič B. Dual concentration-dependent activity of thyroglobulin type-1 domain of testican: specific inhibitor and substrate of cathepsin L. Biol. Chem. 386 (2005) 75-83
11. Nakada M., Miyamori H., Yamashita J., and Sato H. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins. Cancer Res. 63 (2003) 3364-3369
12. Marr H.S., Basalamah M.A., and Edgell C.J. Endothelial cell expression of testican mRNA. Endothelium 5 (1997) 209-219
13. BaSalamah M.A., Marr H.S., Duncan A.W., and Edgell C.J. Testican in human blood. Biochem. Biophys. Res. Commun. 283 (2001) 1083-1090
14. Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O., Tanaka A., Kotani H., Miyajima N., and Nomura N. Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain. DNA Res. 3 (1996) 321-329 341-354
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
16. Gasteiger E., Hoogland C., Gattiker A., Duvaud S., Wilkins M.R., Appel R.D., and Bairoch A. Protein identification and analysis tools on the ExPASy server. In: Walker J.M. (Ed). The Proteomics Protocols Handbook (2005), Humana Press, Totowa, NJ, USA 571-607
17. Radford K., Cavegn C., Bertrand M., Bernard A., Reid S., and Greenfield P. The indirect effects of multiplicity of infection on baculovirus expressed proteins in insect cells: secreted and non-secreted products. Cytotechnology 24 (1997) 73-81
18. Yamada K., Nakajima Y., and Natori S. Production of recombinant sarcotoxin IA in Bombyx mori cells. Biochem. J. 272 (1990) 633-636
19. Pyle L.E., Barton P., Fujiwara Y., Mitchell A., and Fidge N. Secretion of biologically active human proapolipoprotein A-I in a baculovirus-insect cell system: protection from degradation by protease inhibitors. J. Lipid Res. 36 (1995) 2355-2361
20. Rawlings N.D., Pearl L.H., and Buttle D.J. The baculovirus Autographa californica nuclear polyhedrosis virus genome includes a papain-like sequence. Biol. Chem. Hoppe Seyler 373 (1992) 1211-1215
21. Slack J., Kuzio J., and Faulkner P. Characterization of v-cath, a cathepsin L-like proteinase expressed by the baculovirus Autographa californica multiple nuclear polyhedrosis virus. J. Gen. Virol. 76 Pt 5 (1995) 1091-1098
22. Wickham T.J., and Nemerow G.R. Optimization of growth methods and recombinant protein production in BTI-Tn-5B1-4 insect cells using the baculovirus expression system. Biotechnol. Prog. 9 (1993) 25-30
23. Gotoh T., Miyazaki Y., Kikuchi K., and Bentley W.E. Investigation of sequential behavior of carboxyl protease and cysteine protease activities in virus-infected Sf-9 insect cell culture by inhibition assay. Appl. Microbiol. Biotechnol. 56 (2001) 742-749
24. Bonnet F., Perin J.P., Maillet P., Jolles P., and Alliel P.M. Characterization of a human seminal plasma glycosaminoglycan-bearing polypeptide. Biochem. J. 288 Pt 2 (1992) 565-569
25. Lopez M., Tetaert D., Juliant S., Gazon M., Cerutti M., Verbert A., and Delannoy P. O-Glycosylation potential of lepidopteran insect cell lines. Biochim. Biophys. Acta 1427 (1999) 49-61
26. Kuroda K., Hauser C., Rott R., Klenk H.D., and Doerfler W. Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector. EMBO J. 5 (1986) 1359-1365
27. Jarvis D.L., and Summers M.D. Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells. Mol. Cell Biol. 9 (1989) 214-223
28. Chen W.Y., Shen Q.X., and Bahl O.P. Carbohydrate variant of the recombinant beta-subunit of human choriogonadotropin expressed in baculovirus expression system. J. Biol. Chem. 266 (1991) 4081-4087
29. Veit M., Sott C., Borchers K., Ludwig H., and Schmidt M.F. Structure, function, and intracellular localization of glycoprotein B of herpesvirus simian agent 8 expressed in insect and mammalian cells. Arch. Virol. 133 (1993) 335-347
30. Grabenhorst E., Hofer B., Nimtz M., Jager V., and Conradt H.S. Biosynthesis and secretion of human interleukin 2 glycoprotein variants from baculovirus-infected Sf21 cells. Characterization of polypeptides and posttranslational modifications. Eur. J. Biochem. 215 (1993) 189-197
31. Kohfeldt E., Maurer P., Vannahme C., and Timpl R. Properties of the extracellular calcium binding module of the proteoglycan testican. FEBS Lett. 414 (1997) 557-561
32. Lenarčič B., Ritonja A., Štrukelj B., Turk B., and Turk V. Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain. J. Biol. Chem. 272 (1997) 13899-13903
33. Bevec T., Stoka V., Pungerčič G., Dolenc I., and Turk V. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J. Exp. Med. 183 (1996) 1331-1338
34. Lenarčič B., and Turk V. Thyroglobulin type-1 domains in equistatin inhibit both papain-like cysteine proteinases and cathepsin D. J. Biol. Chem. 274 (1999) 563-566
35. Hutchinson W.L., Coll A.P., Gallimore J.R., Tennent G.A., and Pepys M.B. Is leptin an important physiological regulator of CRP?. Nat. Med. 13 (2007) 17-18 (author reply 19-21)
36. Chen K., Li F., Li J., Cai H., Strom S., Bisello A., Kelley D.E., Friedman-Einat M., Skibinski G.A., McCrory M.A., Szalai A.J., and Zhao A.Z. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat. Med. 12 (2006) 425-432
37. Schumaker V.N., Zavodszky P., and Poon P.H. Activation of the first component of complement. Annu. Rev. Immunol. 5 (1987) 21-42
38. Arlaud G.J., Gaboriaud C., Thielens N.M., Budayova-Spano M., Rossi V., and Fontecilla-Camps J.C. Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity. Mol. Immunol. 39 (2002) 383-394
39. Krumdieck R., Höök M., Rosenberg L., and Volanakis J. The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J. Immunol. 149 (1992) 3695-3701
40. Sjöberg A., Onnerfjord P., Mörgelin M., Heinegård D., and Blom A. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J. Biol. Chem. 280 (2005) 32301-32308
41. Afagh A., Cummings B., Cribbs D., Cotman C., and Tenner A. Localization and cell association of C1q in Alzheimer's disease brain. Exp. Neurol. 138 (1996) 22-32
42. Fonseca M., Zhou J., Botto M., and Tenner A. Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. J. Neurosci. 24 (2004) 6457-6465